Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies? Read more about Is routine computed tomographic scanning justified in the first week of persistent febrile neutropenia in children with malignancies?
Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Read more about Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality.
Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients. Read more about Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study. Read more about A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) study.
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma. Read more about Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study. Read more about Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
Ionizing radiation: an element of danger in every procedure. Read more about Ionizing radiation: an element of danger in every procedure.
Osteosarcoma in children 5 years of age or younger at initial diagnosis. Read more about Osteosarcoma in children 5 years of age or younger at initial diagnosis.
Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group. Read more about Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group.
Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow. Read more about Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
